Sangamo BioSciences Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

15.28USD
4:00pm EDT
Change (% chg)

$-0.40 (-2.55%)
Prev Close
$15.68
Open
$15.68
Day's High
$15.68
Day's Low
$14.89
Volume
177,281
Avg. Vol
312,861
52-wk High
$19.25
52-wk Low
$9.41

SGMO.OQ

Chart for SGMO.OQ

About

Sangamo Biosciences, Inc., is a clinical stage biopharmaceutical company. The Company is focused on the research, development and commercialization of engineered DNA-binding proteins for the development of therapeutic strategies for unmet medical needs. The Company’s mission is to develop ZFP Therapeutics, which is human... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $1,084.59
Shares Outstanding(Mil.): 69.17
Dividend: --
Yield (%): --

Financials

  SGMO.OQ Industry Sector
P/E (TTM): -- 139.89 41.18
EPS (TTM): -0.40 -- --
ROI: -14.97 -0.84 16.23
ROE: -16.09 -2.62 17.07
Search Stocks

Competitors

  Price Chg
Novo Nordisk A/S (NOVOb.CO) kr.377.00 +5.00
Pfizer Inc. (PFE.N) $34.33 -0.46
Novartis AG (NOVN.VX) CHF96.45 +0.30
Merck & Co., Inc. (MRK.N) $56.86 -0.62
Roche Holding Ltd. (ROG.VX) CHF267.40 -0.70
Bayer AG (BAYGn.DE) €140.30 +0.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €92.93 +1.00
GlaxoSmithKline plc (GSK.L) 1,565.50p +19.50
Amgen, Inc. (AMGN.OQ) $157.10 -2.75

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks